Kevin W. McCabe, Director
Mr. McCabe is a director in the Biotechnology/Chemical and Litigation Groups at Washington, DC-based intellectual property specialty law firm Sterne, Kessler, Goldstein & Fox P.L.L.C. He represents clients in complex multi-jurisdiction, multi-party, and multi-patent litigations, including Paragraph IV ANDA litigations. and he has argued interference cases before The Board of Patent Appeals and Interferences and has participated in appeals to the Federal Circuit. He further specializes in complex client counseling issues, such as product clearance opinions, patent validity and infringement opinions, performing due diligence investigations, and drafting and negotiating agreements. He also has extensive experience in reexaminations, especially those concurrently involved in litigation. He has extensive experience in drafting and prosecuting patent applications in the biotechnology and chemical areas. The patent applications that he has prepared and prosecuted range from medical devices and medical equipment, software, bioinformatics, immunology, microbiology, molecular and cellular biology, biochemistry, immunodiagnostic assays, and therapeutic methods. He has represented a broad range of clients, from Fortune 100 companies and large international conglomerates to non-profit foundations and small start-up companies.
- Sterne, Kessler, Goldstein & Fox P.L.L.C.
Articles in the National Law Review database by Kevin W. McCabe:
- Federal Circuit Upholds the Patentability of Isolated DNA in Association for Molecular Pathology v. Myriad (Posted On Tue, 2011-08-02 00:09)
- Agree to Assign vs. Hereby Assign: In Stanford v. Roche, the Wording of Assignment Agreements Determines Patent Ownership (Posted On Fri, 2011-06-10 01:11)
- The Medical Device Rodeo: Harnessing Innovation (Posted On Mon, 2010-10-11 11:19)